Drug Pipeline

Paxlovid Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
1
Phase 3
4
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-02 NCT04746183
AGILE (Early Phase Platform Trial for COVID-19)		 date change Primary completion pushed: 2026-07-31 -> 2027-03-31
2026-06-02 NCT04746183
AGILE (Early Phase Platform Trial for COVID-19)		 date change Completion pushed: 2026-07-31 -> 2027-03-31
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-19 NCT07597902 SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 3
1
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04381936 Randomised Evaluation of COVID-19 Therapy Pneumonia Recruiting
Phase 2
NCT07157007 Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With… COVID - 19 Recruiting
NCT07597902 SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction Post-acute Sequelae of COVID-19 Not Yet Recruiting
Phase 1/2
NCT04746183 AGILE (Early Phase Platform Trial for COVID-19) Covid19 Recruiting
Sponsors Running Paxlovid Trials
University of Oxford (1) University of Liverpool (1) Traws Pharma, Inc. (1) Icahn School of Medicine at Mount Sinai (1)
Get alerts when Paxlovid trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free